Patents Assigned to Five3 Genomics, LLC
-
Patent number: 12354709Abstract: Contemplated systems and methods employ chimeric reference sequences that include a plurality of viral genome sequences to identify/quantify integration and co-amplification events. Most typically, the viral genome sequences are organized in the chimeric reference sequences as single chromosomes and the chimeric reference sequences are in BAM format.Type: GrantFiled: September 5, 2019Date of Patent: July 8, 2025Assignee: Five3 Genomics, LLCInventors: John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz, Shahrooz Rabizadeh, Nicole Hensley, Patrick Soon-Shiong
-
Patent number: 11361844Abstract: Contemplated systems and methods employ chimeric reference sequences that include a plurality of viral genome sequences to identify/quantify integration and co-amplification events. Most typically, the viral genome sequences are organized in the chimeric reference sequences as single chromosomes and the chimeric reference sequences are in BAM format.Type: GrantFiled: July 11, 2018Date of Patent: June 14, 2022Assignee: Five3 Genomics, LLCInventors: John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz, Shahrooz Rabizadeh, Nicole Hensley, Patrick Soon-Shiong
-
Patent number: 11183269Abstract: Systems and methods of genomic analysis are presented that provide a framework to determine a tumor's clonality, the number and proportion of all major clones, and the variants that distinguish them. Contemplated systems and methods also allow phasing mutations to parental alleles to so time their emergence within the population of tumor cells, and provide an accurate estimate of the amount of contaminating normal tissue that was present in the tumor biopsy.Type: GrantFiled: November 7, 2013Date of Patent: November 23, 2021Assignee: Five3 Genomics, LLCInventor: John Zachary Sanborn
-
Patent number: 10961586Abstract: Contemplated systems and methods allow for computational genomic analysis using paired-end sequence analysis and split read refinement to thereby identify high-confidence breakpoints associated with high copy numbers and orientation of rearrangements, which is then the basis for full reconstruction of double minutes (DM). In especially preferred aspects, the DM will also include an oncogene or tumor suppressor gene, and/or may be found in blood or blood derived fluids.Type: GrantFiled: February 22, 2017Date of Patent: March 30, 2021Assignee: Five3 Genomics, LLCInventors: John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz
-
Patent number: 10774384Abstract: Contemplated systems and methods allow for computational genomic analysis using paired-end sequence analysis and split read refinement to thereby identify high-confidence breakpoints associated with high copy numbers and orientation of rearrangements, which is then the basis for full reconstruction of double minutes (DM). In especially preferred aspects, the DM will also include an oncogene or tumor suppressor gene, and/or may be found in blood or blood derived fluids.Type: GrantFiled: April 15, 2016Date of Patent: September 15, 2020Assignee: Five3 Genomics, LLCInventors: John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz
-
Patent number: 10733701Abstract: Systems and methods for dynamic visualization of genomic data are provided in which a genomic visualization system adapts presentation of information content according to scale-relevant annotations within a sequence object.Type: GrantFiled: October 24, 2018Date of Patent: August 4, 2020Assignee: Five3 Genomics, LLCInventors: Charles Joseph Vaske, John Zachary Sanborn, Stephen Charles Benz
-
Patent number: 10614910Abstract: Omics patient data are analyzed using sequences or diff objects of tumor and matched normal tissue to identify patient and disease specific mutations, using transcriptomic data to identify expression levels of the mutated genes, and pathway analysis based on the so obtained omic data to identify specific pathway characteristics for the diseased tissue. Most notably, many different tumors have shared pathway characteristics, and identification of a pathway characteristic of a tumor may thus indicate effective treatment options ordinarily not considered when tumor analysis is based on anatomical tumor type only.Type: GrantFiled: June 1, 2015Date of Patent: April 7, 2020Assignees: NANTOMICS, LLC, NANT HOLDINGS IP, LLC, FIVE3 GENOMICS, LLCInventors: Shahrooz Rabizadeh, John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz, Patrick Soon-Shiong
-
Publication number: 20190392921Abstract: Contemplated systems and methods employ chimeric reference sequences that include a plurality of viral genome sequences to identify/quantify integration and co-amplification events. Most typically, the viral genome sequences are organized in the chimeric reference sequences as single chromosomes and the chimeric reference sequences are in BAM format.Type: ApplicationFiled: September 5, 2019Publication date: December 26, 2019Applicants: FIVE3 GENOMICS, LLC, NANT HOLDINGS IP, LLCInventors: John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz, Shahrooz Rabizadeh, Nicole Hensley, Patrick Soon-Shiong
-
Patent number: 10193956Abstract: “Omic” digital data transport systems and methods are disclosed. The disclosed systems and methods employ a transport server that assembles a transport group larger numbers of omic output files on the basis of machine specific annotation from one or more sequencing devices and user input related to one or more attributes for the omic output files.Type: GrantFiled: November 13, 2014Date of Patent: January 29, 2019Assignee: FIVE3 GENOMICS, LLCInventors: Stephen Charles Benz, John Zachary Sanborn, Charles Joseph Vaske
-
Patent number: 10192027Abstract: Contemplated systems and methods integrate genomic/exomic data with transcriptomic data by correlating a cancer associated mutation in the genome/exome with the transcription level of the affected gene carrying the mutation, particularly where the mutation is a 3-terminal nonsense mutation.Type: GrantFiled: March 25, 2015Date of Patent: January 29, 2019Assignee: FIVE3 GENOMICS, LLCInventor: John Zachary Sanborn
-
Patent number: 10176295Abstract: Contemplated systems and methods employ chimeric reference sequences that include a plurality of viral genome sequences to identify/quantify integration and co-amplification events. Most typically, the viral genome sequences are organized in the chimeric reference sequences as single chromosomes and the chimeric reference sequences are in BAM format.Type: GrantFiled: September 26, 2014Date of Patent: January 8, 2019Assignees: Five3 Genomics, LLC, Nant Holdings IP, LLCInventors: John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz, Shahrooz Rabizadeh, Nicole Hensley, Patrick Soon-Shiong